Fundraising Fox
Pilatus Biosciences
1 known investors
Find your way into Pilatus Biosciences
Sign up to find every way you can get introduced to Pilatus Biosciences
- Your email: who you already know at Pilatus Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pilatus Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Pilatus Biosciences develops first-in-class antibodies and bifunctional proteins that target metabolic checkpoints to reprogram the immune microenvironment for treating cancer and immune-related diseases. Its lead candidate, an anti-CD36 monoclonal antibody, is in Phase 1 clinical trials for advanced solid tumors.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Pilatus Biosciences do?
- Pilatus Biosciences develops first-in-class antibodies and bifunctional proteins that target metabolic checkpoints to reprogram the immune microenvironment for treating cancer and immune-related diseases. Its lead candidate, an anti-CD36 monoclonal antibody, is in Phase 1 clinical trials for advanced solid tumors.
- Who founded Pilatus Biosciences?
- Pilatus Biosciences was founded by Raven Lin.
- Who are Pilatus Biosciences's investors?
- Pilatus Biosciences's investors include Mosaic Venture Lab.